STOCK TITAN

[144] Durect Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Durect Corp (DRRX) filed a Form 144 reporting a proposed sale of 5,500 common shares through Morgan Stanley Smith Barney LLC on 09/10/2025. The filing shows the shares were acquired and will be paid for on 09/10/2025 via a stock option exercise and payment in cash. The aggregate market value of the shares at filing is reported as $10,623.80 and the issuer’s number of shares outstanding is listed as 31,054,187. The filer reports no securities sold in the past three months and includes the standard representation that they are not aware of undisclosed material adverse information.

Durect Corp (DRRX) ha presentato un Modulo 144 relativo a una proposta di vendita di 5.500 azioni ordinarie tramite Morgan Stanley Smith Barney LLC in data 10/09/2025. Il documento indica che le azioni sono state acquisite e saranno pagate il 10/09/2025 mediante l’esercizio di un’opzione su azioni e pagamento in contanti. Il valore di mercato complessivo delle azioni alla data della comunicazione è riportato in $10.623,80 e il numero di azioni in circolazione dell’emittente è indicato in 31.054.187. Il dichiarante segnala di non aver venduto titoli negli ultimi tre mesi e include la consueta dichiarazione di non essere a conoscenza di informazioni materiali sfavorevoli non divulgate.

Durect Corp (DRRX) presentó un Formulario 144 notificando una propuesta de venta de 5.500 acciones ordinarias a través de Morgan Stanley Smith Barney LLC con fecha 10/09/2025. El registro indica que las acciones fueron adquiridas y se pagarán el 10/09/2025 mediante el ejercicio de una opción sobre acciones y el pago en efectivo. El valor de mercado agregado de las acciones a la fecha de presentación se reporta como $10.623,80 y el número de acciones en circulación del emisor figura como 31.054.187. El declarante informa que no ha vendido valores en los últimos tres meses e incluye la declaración estándar de no tener conocimiento de información adversa material no divulgada.

Durect Corp (DRRX)2025-09-10자로 Morgan Stanley Smith Barney LLC를 통해 5,500 보통주 매도 제안을 보고하는 Form 144를 제출했습니다. 제출서류에 따르면 해당 주식은 취득되었고 2025-09-10스톡옵션 행사현금으로 대금이 지급될 예정입니다. 제출 시점의 총 시가총액은 $10,623.80로 보고되었으며, 발행사의 총 발행주식수는 31,054,187로 기재되어 있습니다. 신고자는 최근 3개월 내에 유가증권을 매도한 사실이 없음을 보고했으며, 공개되지 않은 중요한 불리한 정보가 없음을 확인하는 표준 진술을 포함하고 있습니다.

Durect Corp (DRRX) a déposé un formulaire 144 signalant une proposition de vente de 5 500 actions ordinaires via Morgan Stanley Smith Barney LLC en date du 10/09/2025. Le dossier indique que les actions ont été acquises et seront payées le 10/09/2025 par exercice d’une option sur actions et paiement en espèces. La valeur de marché agrégée des actions à la date du dépôt est déclarée à 10 623,80 $ et le nombre d’actions en circulation de l’émetteur est indiqué à 31 054 187. Le déclarant indique n’avoir vendu aucun titre au cours des trois derniers mois et inclut la déclaration standard selon laquelle il n’a pas connaissance d’informations défavorables importantes non divulguées.

Durect Corp (DRRX) reichte ein Formular 144 ein, in dem ein geplanter Verkauf von 5.500 Stammaktien über Morgan Stanley Smith Barney LLC zum 10.09.2025 gemeldet wird. Die Einreichung gibt an, dass die Aktien erworben wurden und am 10.09.2025 durch Ausübung einer Aktienoption und Zahlung in Bargeld bezahlt werden. Der aggregierte Marktwert der Aktien zum Zeitpunkt der Meldung wird mit $10.623,80 angegeben, und die ausstehenden Aktien des Emittenten werden mit 31.054.187 angegeben. Der Melder berichtet, in den letzten drei Monaten keine Wertpapiere verkauft zu haben, und fügt die übliche Erklärung hinzu, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen bekannt sind.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small insider sale following option exercise; reported quantity is immaterial relative to outstanding shares and likely limited market impact.

The Form 144 documents a proposed sale of 5,500 shares acquired by stock option exercise and to be sold through Morgan Stanley Smith Barney LLC on 09/10/2025 for an aggregate reported market value of $10,623.80. Relative to the reported 31,054,187 shares outstanding, the proposed sale represents a very small fraction of the float. The filing does not report any sales in the prior three months and contains the standard attestation regarding material nonpublic information. Based solely on the information provided, this disclosure is a routine insider liquidity event without additional context indicating material company-level implications.

TL;DR: Routine compliance filing for a securities sale under Rule 144; no governance issues or disclosure red flags are evident in the notice.

The Form 144 shows compliance with Rule 144 requirements: identification of the broker, number of shares to be sold, acquisition method (stock option exercise), and representation regarding material information. There are no reported aggregated sales in the past three months. The filing does not disclose any additional governance matters, change in control, or restriction exceptions. Based strictly on the filing text, it appears to be a standard reporting of an insider sale opportunity rather than an indicator of governance concern.

Durect Corp (DRRX) ha presentato un Modulo 144 relativo a una proposta di vendita di 5.500 azioni ordinarie tramite Morgan Stanley Smith Barney LLC in data 10/09/2025. Il documento indica che le azioni sono state acquisite e saranno pagate il 10/09/2025 mediante l’esercizio di un’opzione su azioni e pagamento in contanti. Il valore di mercato complessivo delle azioni alla data della comunicazione è riportato in $10.623,80 e il numero di azioni in circolazione dell’emittente è indicato in 31.054.187. Il dichiarante segnala di non aver venduto titoli negli ultimi tre mesi e include la consueta dichiarazione di non essere a conoscenza di informazioni materiali sfavorevoli non divulgate.

Durect Corp (DRRX) presentó un Formulario 144 notificando una propuesta de venta de 5.500 acciones ordinarias a través de Morgan Stanley Smith Barney LLC con fecha 10/09/2025. El registro indica que las acciones fueron adquiridas y se pagarán el 10/09/2025 mediante el ejercicio de una opción sobre acciones y el pago en efectivo. El valor de mercado agregado de las acciones a la fecha de presentación se reporta como $10.623,80 y el número de acciones en circulación del emisor figura como 31.054.187. El declarante informa que no ha vendido valores en los últimos tres meses e incluye la declaración estándar de no tener conocimiento de información adversa material no divulgada.

Durect Corp (DRRX)2025-09-10자로 Morgan Stanley Smith Barney LLC를 통해 5,500 보통주 매도 제안을 보고하는 Form 144를 제출했습니다. 제출서류에 따르면 해당 주식은 취득되었고 2025-09-10스톡옵션 행사현금으로 대금이 지급될 예정입니다. 제출 시점의 총 시가총액은 $10,623.80로 보고되었으며, 발행사의 총 발행주식수는 31,054,187로 기재되어 있습니다. 신고자는 최근 3개월 내에 유가증권을 매도한 사실이 없음을 보고했으며, 공개되지 않은 중요한 불리한 정보가 없음을 확인하는 표준 진술을 포함하고 있습니다.

Durect Corp (DRRX) a déposé un formulaire 144 signalant une proposition de vente de 5 500 actions ordinaires via Morgan Stanley Smith Barney LLC en date du 10/09/2025. Le dossier indique que les actions ont été acquises et seront payées le 10/09/2025 par exercice d’une option sur actions et paiement en espèces. La valeur de marché agrégée des actions à la date du dépôt est déclarée à 10 623,80 $ et le nombre d’actions en circulation de l’émetteur est indiqué à 31 054 187. Le déclarant indique n’avoir vendu aucun titre au cours des trois derniers mois et inclut la déclaration standard selon laquelle il n’a pas connaissance d’informations défavorables importantes non divulguées.

Durect Corp (DRRX) reichte ein Formular 144 ein, in dem ein geplanter Verkauf von 5.500 Stammaktien über Morgan Stanley Smith Barney LLC zum 10.09.2025 gemeldet wird. Die Einreichung gibt an, dass die Aktien erworben wurden und am 10.09.2025 durch Ausübung einer Aktienoption und Zahlung in Bargeld bezahlt werden. Der aggregierte Marktwert der Aktien zum Zeitpunkt der Meldung wird mit $10.623,80 angegeben, und die ausstehenden Aktien des Emittenten werden mit 31.054.187 angegeben. Der Melder berichtet, in den letzten drei Monaten keine Wertpapiere verkauft zu haben, und fügt die übliche Erklärung hinzu, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen bekannt sind.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed by Durect Corp (DRRX) report?

The Form 144 reports a proposed sale of 5,500 common shares to be sold through Morgan Stanley Smith Barney LLC on 09/10/2025, with an aggregate market value of $10,623.80.

How were the shares acquired according to the filing?

The filing states the shares were acquired on 09/10/2025 via a stock option exercise, and payment was made in cash on that date.

How many shares outstanding does the filing list for the issuer?

The Form 144 lists 31,054,187 shares outstanding for the issuer.

Did the filer report any securities sold in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.

Who is the broker named in the notice?

The broker named is Morgan Stanley Smith Barney LLC located at Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004.
DURECT

NASDAQ:DRRX

DRRX Rankings

DRRX Latest News

DRRX Latest SEC Filings

DRRX Stock Data

59.31M
27.26M
12.67%
23.58%
1.11%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CUPERTINO